Purple Biotech Ltd
TASE:PPBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Purple Biotech Ltd
TASE:PPBT
|
IL |
|
MVB Financial Corp
NASDAQ:MVBF
|
US |
|
Orient Overseas (International) Ltd
F:ORI
|
HK |
|
Intiland Development Tbk PT
IDX:DILD
|
ID |
Intrinsic Value
Is PPBT undervalued or overvalued?
See the intrinsic value estimate for Purple Biotech Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Purple Biotech Does
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways.
- Headquarters
- Israel IL
- Employees
- 10
- IPO date
- Sep 3, 1978
Revenue & Expenses Breakdown
Purple Biotech Ltd
Earnings Waterfall
Purple Biotech Ltd
The intrinsic value for Purple Biotech Ltd (PPBT) under the Base Case is hidden ILS.
Compared with the current market price of 1 ILS, the stock appears hidden.